SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-062653
Filing Date
2018-11-30
Accepted
2018-11-30 17:04:44
Documents
1
Period of Report
2018-11-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv507903_4.html 4  
1 OWNERSHIP DOCUMENT tv507903_4.xml 4 4112
  Complete submission text file 0001144204-18-062653.txt   5838
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 6 HADISHON STREEET JERUSALEM ISRAEL 96596 L3 00000
Business Address
ARBEL IRIT (Reporting) CIK: 0001245607 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36641 | Film No.: 181211855